Prostatic Hyperplasia Treatment and Cancer Prevention

• Status: Not yet recruiting
• Trial end date: 2021-12-01
• Target enrollment: 0
• Participant gender: Male

Summary

Treatment of patients with prostatic hyperplasia with topical papaverine.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Manchanda Medical Clinic
• Treatments: Papaverine

Criteria

Inclusion Criteria:

• patients with symptoms e.g. obstructive voiding, hyperplasia and high PSA

Exclusion Criteria:

• patients on chemotherapy

• abnormal lab values e.g. liver function, GFR and CAD